Inventor · disambiguated record
William A. Garland
Also filed as: GARLAND WILLIAM · GARLAND WILLIAM A · GARLAND WILLIAM ARTHUR
55 granted patents·15 pending applications·315 citations·filing 1995–2025
98Inventor score
Top patents by PatentIndex Score
70 records- 0193US7829674B2Compositions and methods for binding sphingosine-1-phosphateLPATH INC·Filed 2007·Granted Nov 9, 2010·20 cites·6 claims
- 0293US6486349B1Amide therapeutics and methods for treating inflammatory bowel diseaseCENTAUR PHARMACEUTICALS INC·Filed 2000·Granted Nov 26, 2002·49 cites·21 claims
- 0392USRE48253EMethotrexate adjuvants to reduce toxicity and methods for using the sameTOSK INC·Filed 2018·Granted Oct 13, 2020·5 cites·29 claims
- 0490US7998967B2Methotrexate adjuvants to reduce toxicity and methods for using the sameTOSK INC·Filed 2009·Granted Aug 16, 2011·15 cites·13 claims
- 0589US11446303B2Uridine phosphorylase (UPase) inhibitors for treatment of liver conditionsTOSK INC·Filed 2020·Granted Sep 20, 2022·3 cites·18 claims
- 0689US8614103B2Compositions and methods for treating sphingosine-1-phosphate (S1P) related ocular diseases and conditionsSABBADINI ROGER A·Filed 2007·Granted Dec 24, 2013·6 cites·9 claims
- 0787US5756548AAcetamidobenzamide compounds for neurodegenerative disordersCENTAUR PHARMACEUTICALS INC·Filed 1997·Granted May 26, 1998·21 cites·8 claims
- 0886US8158124B2Compositions and methods for binding lysophosphatidic acidSABBADINI ROGER A·Filed 2008·Granted Apr 17, 2012·10 cites·10 claims
- 0986US6258852B1Aryl nitrone therapeutics for the treatment of inflammatory bowel diseaseCENTAUR PHARMACEUTICALS INC·Filed 2000·Granted Jul 10, 2001·20 cites·5 claims
- 1086US5659082ANitro- and aminobenzamide compounds for neurodegenerative disordersCENTAUR PHARMACEUTICALS INC·Filed 1995·Granted Aug 19, 1997·29 cites·11 claims
- 1185US8025877B2Methods of using humanized antibodies and compositions for binding sphingosine-1-phosphateLPATH INC·Filed 2008·Granted Sep 27, 2011·5 cites·18 claims
- 1284US11945803B2Modulators of RAS GTPaseTOSK INC·Filed 2019·Granted Apr 2, 2024·3 cites·9 claims
- 1384US8853227B2Methotrexate adjuvants to reduce toxicity and methods for using the sameGARLAND WILLIAM A·Filed 2011·Granted Oct 7, 2014·8 cites·17 claims
- 1484US8796429B2Bioactive lipid derivatives, and methods of making and using sameSABBADINI ROGER A·Filed 2007·Granted Aug 5, 2014·2 cites·6 claims
- 1584US8067549B2Humanized antibodies and compositions for binding sphingosine-1-phosphateSABBADINI ROGER A·Filed 2008·Granted Nov 29, 2011·4 cites·12 claims
- 1683US9382287B2Methotrexate adjuvants to reduce toxicity and methods for using the sameTOSK INC·Filed 2014·Granted Jul 5, 2016·5 cites·16 claims
- 1783US8444970B2Compositions and methods for treating ocular diseases and conditionsSABBADINI ROGER A·Filed 2007·Granted May 21, 2013·2 cites·11 claims
- 1882US8604172B2Humanized antibody compositions and methods for binding lysophosphatidic acidSABBADINI ROGER A·Filed 2010·Granted Dec 10, 2013·5 cites·5 claims
- 1981US8138356B2Chemical inhibitors of inhibitors of differentiationCHAUDHARY JAIDEEP·Filed 2008·Granted Mar 20, 2012·15 cites·1 claims
- 2080US9061038B2Doxorubicin adjuvants to reduce toxicity and methods for using the sameGARLAND WILLIAM A·Filed 2012·Granted Jun 23, 2015·5 cites·19 claims
- 2179US8026342B2Compositions and methods for binding sphingosine-1-phosphateLPATH INC·Filed 2008·Granted Sep 27, 2011·2 cites·11 claims
- 2277US12486255B2Modulators of RAS GTPaseTOSK INC·Filed 2024·Granted Dec 2, 2025·0 cites·17 claims
- 2376US8222373B2Humanized antibodies and compositions for binding sphingosine-1-phosphateSABBADINI ROGER A·Filed 2008·Granted Jul 17, 2012·1 cites·8 claims
- 2475US9217749B2Immune-derived moieties reactive against lysophosphatidic acidSABBADINI ROGER A·Filed 2007·Granted Dec 22, 2015·1 cites·5 claims
- 2574US6509378B2Acetamidobenzamide compounds for neurodegenerative disordersCENTAUR PHARMACEUTICALS INC·Filed 2001·Granted Jan 21, 2003·4 cites·32 claims
- 2674US2025049834A1Methods and Compositions for Treating MucositisTOSK INC·Filed 2024·Application pending·0 cites
- 2773US7005546B2Acetamidobenzamide compounds for neurodegenerative disordersRENOVIS INC·Filed 2004·Granted Feb 28, 2006·2 cites·19 claims
- 2871US6759433B2Acetamidobenzamide compounds for neurodegenerative disordersRENOVIS INC·Filed 2002·Granted Jul 6, 2004·3 cites·10 claims
- 2970US6545056B1Aryl nitrone therapeutics and methods for treating inflammatory bowel diseaseCENTAUR PHARMACEUTICALS INC·Filed 2000·Granted Apr 8, 2003·5 cites·23 claims
- 3069US7629131B2Rabbit monoclonal antibodies against mouse/human Id3 proteinsBIOCHECK INC·Filed 2007·Granted Dec 8, 2009·1 cites·13 claims
- 3168US12194043B2Uridine phosphorylase inhibitors to treat or prevent pulmonary diseaseTOSK INC·Filed 2021·Granted Jan 14, 2025·0 cites·20 claims
- 3268US5658953APharmaceutical compositions of acetamidobenzamide compounds for neurodegenerative disordersCENTAUR PHARMACEUTICALS INC·Filed 1995·Granted Aug 19, 1997·9 cites·26 claims
- 3367US12109222B2Methods and compositions for treating mucositisTOSK INC·Filed 2021·Granted Oct 8, 2024·0 cites·20 claims
- 3467US7956173B2Nucleic acids coding for humanized antibodies for binding sphingosine-1-phosphateLPATH INC·Filed 2008·Granted Jun 7, 2011·0 cites·17 claims
- 3563US2024091228A1Uridine Phosphorylase Inhibitors to Prevent or Treat Drug-Induced Pulmonary DysfunctionTOSK INC·Filed 2023·Application pending·0 cites
- 3663US2023255971A1Uridine Phosphorylase (UPase) Inhibitors for Treatment of Liver ConditionsTOSK INC·Filed 2022·Application pending·0 cites
- 3762US8227517B2Doxorubicin adjuvants to reduce toxicity and methods for using the sameGARLAND WILLIAM A·Filed 2009·Granted Jul 24, 2012·0 cites·27 claims
- 3862US5955506ABenzamides for neurodegenerative disorder treatmentCENTAUR PHARMACEUTICALS INC·Filed 1996·Granted Sep 21, 1999·6 cites·24 claims
- 3961US12508265B2Methods and compositions for reducing radiation induced toxicityTOSK INC·Filed 2021·Granted Dec 30, 2025·0 cites·19 claims
- 4061US9163091B2Compositions and methods for binding lysophosphatidic acidSABBADINI ROGER A·Filed 2009·Granted Oct 20, 2015·0 cites·6 claims
- 4160US7517663B2Rabbit monoclonal antibody against Id1 proteinBIOCHECK INC·Filed 2006·Granted Apr 14, 2009·1 cites·13 claims
- 4260US6066765AAcetamidobenzamide compounds for neurodegenerative disordersCENTAUR PHARMACEUTICALS INC·Filed 1998·Granted May 23, 2000·4 cites·5 claims
- 4360US5643965AAminobenzamide compounds for the treatment of neurodegenerative disordersCENTAUR PHARMACEUTICALS INC·Filed 1995·Granted Jul 1, 1997·6 cites·8 claims
- 4458US2020390074A1Non-Mammalian RAS Transgenic Animal ModelTOSK INC·Filed 2020·Application pending·0 cites
- 4558US2015031055A1Novel bioactive lipid derivatives, and methods of making and using the sameLPATH INC·Filed 2014·Application pending·0 cites
- 4657US2006100461A1Acetamidobenzamide compounds for neurodegenerative disordersRENOVIS INC·Filed 2005·Application pending·0 cites
- 4757US2008213274A1Compositions and methods for the treatment and prevention of fibrotic, inflammatory, and neovascularization conditions of the eyeSABBADINI ROGER A·Filed 2007·Application pending·0 cites
- 4856US2009220523A1Compositions and methods for the treatment and prevention of fibrotic, inflammatory and neovascularization conditionsLPATH INC·Filed 2006·Application pending·0 cites
- 4956US2025222000A1Uridine Phosphorylase Inhibitors to Treat or Prevent Pulmonary DiseaseTOSK INC·Filed 2025·Application pending·0 cites
- 5056US2007148168A1Compositions and methods for the treatment and prevention of fibrotic, inflammatory and neovascularization conditionsSABBADINI ROGER A·Filed 2006·Application pending·0 cites
Showing the top 50 of 70 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when William A. Garland files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →